BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
· Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase..
· Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase..
· The 17th AFF, themed *Multilateral Cooperation for a Shared Tomorrow,* is taking place at the HKCEC for two consecutive days...
Issuer: Trade Republic Bank GmbH / Key word(s): Regulatory Approval/Strategic Company Decision
06.12.2023 / 08:00..